Home
Conditions
Triple Negative Breast Neoplasms

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies

Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Not Yet Recruiting

Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

NCT07527819

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +18 more
Locations: Chris O'Brien Lifehouse Camperdown, New South Wales, Australia

Mater Hospital Sydney Sydney, New South Wales, Australia

Lyell McEwin Hospital Adelaide, South Australia, Australia

Icon Cancer Centre Hobart, Tasmania, Australia

View Trial Details

Not Yet Recruiting

Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer

NCT07528768

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Triple-negative Breast Cancer, +6 more
Locations: The Queen Elizabeth Hospital Bridgetown, Saint Michael, Barbados

The University of the West Indies, Mona Mona, Kingston, Jamaica

St. James Medical Complex Port of Spain, Saint James, Trinidad and Tobago

View Trial Details

Not Yet Recruiting

Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.

NCT02802423

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC

NCT07523789

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: the First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

QLC5513 Alone or in Combination With QL1706 in Previously Treated Advanced or Metastatic TNBC.

NCT07509515

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC

NCT06396754

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Phase II Study of HLX43 Monotherapy or Combined With Immune Checkpoint Inhibitors in Patients With Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer.

NCT07487519

Conditions: Breast Cancer (Triple Negative Breast Cancer (TNBC)), Breast Diseases, Breast Neoplasms, +5 more
Locations: Harbin Medical University Affiliated Cancer Hospital Harbin, Heilongjiang, China

View Trial Details

Not Yet Recruiting

Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy

NCT07486687

Conditions: Breast Cancer Stage II, Breast Cancer Stage III, Breast Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging

NCT07478705

Conditions: Breast Diseases, Breast Neoplasms, CtDNA, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer

NCT07466303

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations: the First Affiliated Hospital of the Air Force Medical University Xi'an, China

View Trial Details

Triple Negative Breast Neoplasms

Triple Negative Breast Neoplasms trial results

Related conditions